REM sleep physiology and selective neuronal vulnerability in amyotrophic lateral sclerosis by Turner, M, Al-Chalabi, A

Young-onset amyotrophic lateral sclerosis: Historical and other observations by Turner, M, Barnwell, J, Al-Chalabi, A, Eisen, A

Young-onset amyotrophic lateral sclerosis: historical and other observations. by Turner, M, Barnwell, J, Al-Chalabi, A, Eisen, A

Analysis of terms used for the diagnosis and classification of amyotrophic lateral sclerosis and motor neuron disease by Rutter-Locher, Z, Turner, M, Leigh, P, Al-Chalabi, A

The ALSFRS as an outcome measure in therapeutic trials and its relationship to symptom onset by Proudfoot, M, Jones, A, Talbot, K, Al-Chalabi, A, Turner, M

Prolonged survival in motor neuron disease: a descriptive study of the King's database 1990-2002. by Turner, M, Parton, M, Shaw, C, Leigh, P, Al-Chalabi, A

Multi-Centre Clinical Trial Data Using the King's Amyotrophic Lateral Sclerosis (ALS) Staging System by Balendra, R, Jones, A, Turner, M, Leigh, N, Al-Chalabi, A, Grp, M

Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis. by Turner, M, Bakker, M, Sham, P, Shaw, C, Leigh, P, Al-Chalabi, A

Validation of an Amyotrophic Lateral Sclerosis Staging System Using Clinical Trial Data by Jones, A, Balendra, R, McCrone, P, Turner, M, Leigh, N, Al-Chalabi, A

Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: Studies with [11C]flumazenil PET by Turner, M, Hammers, A, Al-Chalabi, A, Shaw, C, Andersen, P, Brooks, D, Leigh, P

Cortical involvement in four cases of primary lateral sclerosis using [(11)C]-flumazenil PET. by Turner, M, Hammers, A, Al-Chalabi, A, Shaw, C, Andersen, P, Brooks, D, Leigh, P

Quantifying disease progression in amyotrophic lateral sclerosis. by Simon, N, Turner, M, Vucic, S, Al-Chalabi, A, Shefner, J, Lomen-Hoerth, C, Kiernan, M

Amyotrophic lateral sclerosis and cancer: a register-based study in Sweden. by Fang, F, Al-Chalabi, A, Ronnevi, L, Turner, M, Wirdefeldt, K, Kamel, F, Ye, W

Concordance between site of onset and limb dominance in amyotrophic lateral sclerosis. by Turner, M, Wicks, P, Brownstein, C, Massagli, M, Toronjo, M, Talbot, K, Al-Chalabi, A

Cortical 5-HT1A receptor binding in patients with homozygous D90A SOD1 vs sporadic ALS. by Turner, M, Rabiner, E, Al-Chalabi, A, Shaw, C, Brooks, D, Leigh, P, Andersen, P

Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: studies with [11C]flumazenil PET. by Turner, M, Hammers, A, Al-Chalabi, A, Shaw, C, Andersen, P, Brooks, D, Leigh, P

Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis. by Abrahams, S, Goldstein, L, Al-Chalabi, A, Pickering, A, Morris, R, Passingham, R, Brooks, D, Leigh, P

Comparison of two percutaneous radiological gastrostomy tubes in the nutritional management of ALS patients. by Rio, A, Ampong, M, Turner, M, Shaw, A, Al-Chalabi, A, Shaw, C, Leigh, P, Sidhu, P

Mills' and other isolated upper motor neurone syndromes: in vivo study with 11C-(R)-PK11195 PET. by Turner, M, Gerhard, A, Al-Chalabi, A, Shaw, C, Hughes, R, Banati, R, Brooks, D, Leigh, P

[11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS. by Turner, M, Rabiner, E, Hammers, A, Al-Chalabi, A, Grasby, P, Shaw, C, Brooks, D, Leigh, P